Medical Device Reimbursement De-Mystified Securing Value-Based Payment for Medical Devices in Changing Times

$527.00
Quantity Discounts
1 - 9999
$527.00
1 - 9999
$327.00
1 - 9999
$527.00
1 - 9999
$327.00
With the Supreme Court decision and the FDA user fee reauthorization behind us, companies now have more certainty and new questions about regulatory and reimbursement pathways to securing value-based payment for innovative medical devices.

Arent Fox Senior Health Care Advisor Ed Dougherty will present a webinar sponsored by FDAnews on securing value-based payment for medical devices in the current environment.

The webinar will address best practices and recommend strategies for successful reimbursement planning for medical devices and diagnostics in the US. The discussion will draw together policy and tactics to create a “roadmap” for success.

Register Today

In today’s rapidly changing times, a step-wise, multi-modal approach is needed to survive.  This webinar will address best practices — and proven profitable strategies — in reimbursement planning for medical devices and diagnostics.  It will discuss:

  • The critical link between regulatory and payment strategies
  • Building a global reimbursement and market access plan
  • Knowing the landscape: evolution or revolution?
  • Emerging definitions of “value”
  • Developing an “evidence cascade” to support the value proposition
  • Stakeholder engagement
  • Tactics and case studies

The event will also identify three recent policy developments most likely to impact success in securing payment for value of medical devices and diagnostics.  Addtionally, the webinar will draw together policy and tactics to create a “roadmap” for securing regulatory and reimbursement success.

To guide you down this confusing road, FDAnews has called on one of the industry’s top medical device reimbursement experts, Arent Fox’s Senior Healthcare Advisor Ed Dougherty.

In just 90 minutes, you’ll dig deep into the finer points of device reimbursement strategies and how to prepare for the changes ahead.

Like every FDAnews webinar, Medical Device Reimbursement De-Mystified is convenient to attend. All that’s required is that you be in front of a computer screen at the appointed time, whether you’re at the office or telecommuting from your home office.

Of course, Mr. Dougherty will be on hand to answer all of your questions. Simply submit your questions via email, and you’ll have answers by the time the session ends.
 
Everyone in your organization with a role in reimbursements deserves to take part in this event — and they can do so at a cost that won’t break the budget. You only pay one low registration fee per facility, regardless of how many participate — so spread the word.

Register now

Here’s a suggested list of potential participants from your organization:

  • Senior management
  • Clinical officials
  • CFOs and pricing teams
  • Reimbursement officials at all levels
  • Marketing and sales officials
  • Regulatory and legislative affairs professionals
  • General and corporate counsel
  • New business development
  • Strategic marketing
  • Product development leaders
  • Manufacturing directors
  • Private equity and venture capital professionals

Ed Dougherty, Senior Healthcare Advisor at Arent Fox in Washington, DC, advises medical device, pharmaceutical, diagnostics, biologics and biotech companies in developing and implementing strategies to secure appropriate coverage and value-based reimbursement for novel technologies and mature health care products and services. He helps manufacturers overcome hurdles in the health care reimbursement environment, including evidence planning, payer interaction, coverage, coding, and payment.  Mr. Dougherty also works to enhance collaboration between private industry, public research entities and patient advocacy organizations to accelerate the translation of scientific research into effective therapies for the treatment of rare diseases.  Before joining Arent Fox, Mr. Dougherty worked as a senior vice president and chair of the health and life sciences practice of a national advisory and advocacy firm.  Mr. Dougherty previously directed prospective study design and strategic marketing activities for a Fortune 40 pharmaceutical services company.  He led the strategic consulting group within the medical marketing division of a global contract research organization and coordinated outcomes research and reimbursement support activities for a major health care consulting firm.  Mr. Dougherty is a frequent speaker at industry conferences on health care policy and reimbursement.

Register now!

Date: July 30 – Aug. 17, 2012
Location: Your office or conference room (no need to travel!)
Time: Anytime

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?

Significant tuition discounts are available for three or more sites from
the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 sites – 10%
7-9 sites – 20%
5-6 sites – 15%
10+ sites – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
with any questions.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Cancellations/Substitutions
Registrations may not be cancelled. Please contact customer service to make any substitutions.

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.